Mauvais-Jarvis F
Diabetes. 2017; 66(3):568-570.
PMID: 28223340
PMC: 5319722.
DOI: 10.2337/dbi16-0063.
Della Torre S, Benedusi V, Fontana R, Maggi A
Nat Rev Endocrinol. 2013; 10(1):13-23.
PMID: 24146033
DOI: 10.1038/nrendo.2013.203.
Rettberg J, Yao J, Brinton R
Front Neuroendocrinol. 2013; 35(1):8-30.
PMID: 23994581
PMC: 4024050.
DOI: 10.1016/j.yfrne.2013.08.001.
Tiano J, Mauvais-Jarvis F
Nat Rev Endocrinol. 2012; 8(6):342-51.
PMID: 22330739
DOI: 10.1038/nrendo.2011.242.
Cheang K, Essah P, Sharma S, Wickham 3rd E, Nestler J
Fertil Steril. 2011; 96(2):353-359.e1.
PMID: 21676394
PMC: 3143285.
DOI: 10.1016/j.fertnstert.2011.05.039.
Oestrogens and insulin secretion.
Godsland I
Diabetologia. 2005; 48(11):2213-20.
PMID: 16193292
DOI: 10.1007/s00125-005-1930-0.
Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.
Godsland I, Winkler U, Lidegaard O, Crook D
Drugs. 2000; 60(4):721-869.
PMID: 11085198
DOI: 10.2165/00003495-200060040-00003.
Effect of combined oral contraceptives on glycosylated haemoglobin.
Oakley N, Rostron W
J R Soc Med. 1982; 75(4):234-6.
PMID: 7069693
PMC: 1437663.
DOI: 10.1177/014107688207500405.
Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus.
Kissebah A, Alfarsi S, Evans D, Adams P
J Clin Invest. 1983; 71(3):655-67.
PMID: 6338042
PMC: 436915.
DOI: 10.1172/jci110812.
Cerebral arterial insufficiency and oral contraceptives.
Bickerstaff E, Holmes J
Br Med J. 1967; 1(5542):726-9.
PMID: 6020089
PMC: 1840975.
DOI: 10.1136/bmj.1.5542.726.
Diabetes mellitus--current criteria for laboratory diagnosis.
Alexander R
Calif Med. 1969; 110(2):107-13.
PMID: 5805334
PMC: 1503294.
Observations on some effects of L-triiodothyronine on carbohydrate and lipid metabolism in man.
Stamp T, Doar J, WYNN V
J Clin Pathol. 1969; 22(2):132-5.
PMID: 5776542
PMC: 474021.
DOI: 10.1136/jcp.22.2.132.
Effect of oestrogens and progestogens on liver function in the puerperium.
Clinch J, TINDALL V
Br Med J. 1969; 1(5644):602-5.
PMID: 5766124
PMC: 1982437.
DOI: 10.1136/bmj.1.5644.602.
Oestrogens and thromboembolism.
REID A
Br Med J. 1968; 4(5625):255.
PMID: 5687598
PMC: 1912220.
DOI: 10.1136/bmj.4.5625.255.
Investigation of relation between use of oral contraceptives and thromboembolic disease.
Vessey M, DOLL R
Br Med J. 1968; 2(5599):199-205.
PMID: 5653025
PMC: 1985919.
DOI: 10.1136/bmj.2.5599.199.
Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.
INMAN W, Vessey M
Br Med J. 1968; 2(5599):193-9.
PMID: 5653024
PMC: 1985904.
DOI: 10.1136/bmj.2.5599.193.
Influence of gestogenic contraceptive pills on vaginal candidosis.
Catterall R
Br J Vener Dis. 1971; 47(1):45-7.
PMID: 5550863
PMC: 1048147.
DOI: 10.1136/sti.47.1.45.
[Studies of plasma lipids before and after a 6-month oral therapy with contraceptives].
KAFFARNIK H, Lehnert H, Zofel P, Karsznia R
Klin Wochenschr. 1970; 48(7):439-41.
PMID: 5521257
DOI: 10.1007/BF01487016.
Oral contraceptives and myocardial infarction.
Oliver M
Br Med J. 1970; 2(5703):210-3.
PMID: 5443407
PMC: 1700055.
DOI: 10.1136/bmj.2.5703.210.
Effects of obesity, glucocorticoid, and oral contraceptive therapy on plasma glucose and blood pyruvate levels.
Doar J, WYNN V
Br Med J. 1970; 1(5689):149-52.
PMID: 5413954
PMC: 1699069.
DOI: 10.1136/bmj.1.5689.149.
